TEVA logo

TEVA Stock Overview

Profile

Full Name:

Teva Pharmaceutical Industries Limited

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

Israel

IPO:

February 16, 1982

Indexes:

Not included

Website:

http://www.tevapharm.com

Description:

Teva Pharmaceutical Industries Limited is a multinational pharmaceutical company headquartered in Petah Tikva, Israel. The company specializes in producing generic drugs, active pharmaceutical ingredients, and to a lesser extent, proprietary drugs. The company ranks 16th in the list of the largest pharmaceutical manufacturers and 704th in the ranking of the largest global companies by Forbes Global 2000. Teva has 80 plants in its portfolio and operates in 60 countries. Teva is a member of the American Association of Pharmaceutical Researchers and Manufacturers.

Key Details

Price

$16.62

Market Cap

$18.85 B(Large cap)

Last Dividend

$0.09

TTM Dividend Yield

-

Annual Revenue

$16.54 B(+4.41% YoY)

Annual EPS

-$1.45(-190.00% YoY)

PE Ratio

-

Annual ROE

-23.67%

Annual Debt To Equity

3.31

Beta

0.57

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Jan 29, 2025

Recent annual earnings:

Jan 29, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Nov 27, 2017
Splits

Next split:

N/A

Recent split:

Jul 1, 2004

Analyst ratings

Recent major analysts updates

Jan 30, 25 UBS
Buy
Jan 30, 25 Barclays
Overweight
Jan 23, 25 UBS
Buy
Jan 17, 25 Piper Sandler
Overweight
Dec 18, 24 Barclays
Overweight
Oct 23, 24 Barclays
Overweight
Oct 21, 24 JP Morgan
Neutral
Sep 3, 24 UBS
Buy
Aug 1, 24 Barclays
Overweight
Jul 11, 24 UBS
Buy

Screeners with TEVA included

Growing Shares Outstanding
Stocks below SMA 200
Most recommended stocks
Best performing stocks last 5 years
Stocks below analysts price target
Healthcare sector
All stocks
Israeli stocks
Large cap stocks
Specialty & Generic Drug Manufacturers industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$16.62
TEVA price is $16.62

Price All-time High

$72.00
TEVA price is currently -76.91% below its historical high of $72.00

Price Analysts Target

$23.00
TEVA price is currently -27.73% lower than the consensus analysts' forecast

Price Most Recent Change

-1.41%
TEVA price was down -1.41% on Feb 26, 2025

Price YTD Change

-25.06%
TEVA price is down -25.06% since January 1st

Price 3-Year Change

+98.82%
TEVA price is up +98.82% over the past 3 years

Market cap

Market Cap

$18.85 B
TEVA market capitalization is $18.85 billion

Market Cap 3-Year Change

+104.32%
TEVA market capitalization is up +104.32% over the past 3 years

Market Cap All-time High

$61.23 B
TEVA market capitalization is currently -69.22% below its historical high of $61.23 billion

Market Cap Sector Rank

95.28%
TEVA market capitalization is higher than 95.28% of companies in Healthcare sector

Technical

Beta

0.57
TEVA beta is 0.57

200-day SMA

$17.87
TEVA price is currently -7.01% below its 200-day simple moving average

14-day RSI

34.88
TEVA 14-day relative strength index is 34.88

30-day Relative Volume

0.94
TEVA 30-day relative volume is 0.94

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.09
TEVA last dividend was $0.09 per share, with an ex-dividend date of November 27, 2017

Next Dividend

-
TEVA next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

-
TEVA annual dividend per share value is unknown

Annual Dividend Per Share Sector Rank

-
TEVA annual dividend per share is unknown

Annual Dividend Per Share 1-Year Change

-
TEVA annual dividend per share 1-year change is unknown

Annual Dividend Per Share 3-Year Change

-
TEVA annual dividend per share 3-year change is unknown

Dividend yield

Annual Dividend Yield

-
TEVA annual dividend yield value is unknown

Annual Dividend Yield Sector Rank

-
TEVA annual dividend yield is unknown

Other

Annual Payout Ratio

-
TEVA annual payout ratio value is unknown

Annual Dividends Paid

-
TEVA annual dividends paid value is unknown

Annual FCF

$749.00 M
TEVA annual free cash flow is $749.00 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$16.54 B
TEVA annual revenue is $16.54 billion

Annual Revenue Analysts Estimate

$17.11 B
TEVA annual revenue is currently -3.31% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+4.41%
TEVA annual revenue is up +4.41% year-on-year

Annual Revenue Sector Rank

95.87%
TEVA annual revenue is higher than 95.87% of companies in Healthcare sector

Profit

Annual Gross Profit

$8.06 B
TEVA annual gross profit is $8.06 billion

Annual Gross Margin

48.74%
TEVA annual gross profit margin is 48.74%

Annual Operating Profit

$3.36 B
TEVA annual operating income is $3.36 billion

Annual Operating Margin

20.33%
TEVA annual operating profit margin is 20.33%

Annual Net Income

-$1.64 B
TEVA annual net profit is -$1.64 billion

Annual Net Margin

-9.91%
TEVA annual net profit margin is -9.91%

EPS

Annual EPS

-$1.45
TEVA annual earnings per share is -$1.45

Annual EPS Analysts Estimate

$2.55
TEVA annual earnings per share is currently -156.80% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-190%
TEVA annual earnings per share is down -190% year-on-year

Annual EPS Sector Rank

51.54%
TEVA annual earnings per share is higher than 51.54% of companies in Healthcare sector

ROA & ROE

Annual ROA

-3.96%
TEVA annual return on assets is -3.96%

Annual ROE

-23.67%
TEVA annual return on equity is -23.67%

EBIT & EBITDA

Annual EBIT

-$369.00 M
TEVA annual earnings before interest & taxes is -$369.00 million

Annual EBITDA

$690.00 M
TEVA annual EBITDA is $690.00 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
TEVA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
TEVA price to earnings ratio is unknown

PB Ratio

PB Ratio

3.51
TEVA price to book ratio is 3.51

PB Ratio Sector Rank

73.36%
TEVA price to book ratio is higher than 73.36% of companies in Healthcare sector

PS Ratio

PS Ratio

1.14
TEVA price to sales ratio is 1.14

PS Ratio Sector Rank

27.78%
TEVA price to sales ratio is higher than 27.78% of companies in Healthcare sector

Enterprise value

Enterprise Value

$33.63 B
TEVA enterprise value is $33.63 billion

Enterprise Value Sector Rank

97.18%
TEVA enterprise value is higher than 97.18% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

44.13
TEVA EV/EBITDA is 44.13

EV/EBITDA Sector Rank

96.22%
TEVA EV/EBITDA is higher than 96.22% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.98
TEVA annual current ratio is 0.98

Annual Quick Ratio

0.75
TEVA annual quick ratio is 0.75

Leverage

Annual Debt To Equity

3.31
TEVA annual debt to equity ratio is 3.31

Annual Interest Coverage Ratio

-0.37
TEVA annual interest coverage ratio is -0.37

Risk & Stability

Piotroski F-Score

4
TEVA piotroski f-score is 4

Altman Z-Score

0.18
TEVA altman z-score is 0.18

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$39.33 B
TEVA annual total assets is $39.33 billion

Annual Non Current Assets

$26.77 B
TEVA annual long term assets is $26.77 billion

Annual Current Assets

$12.55 B
TEVA annual total current assets is $12.55 billion

Annual Cash & Cash Equivalents

$3.30 B
TEVA annual cash & cash equivalents is $3.30 billion

Equity

Annual Book Value

$5.37 B
TEVA annual book value is $5.37 billion

Annual Working Capital

-$244.00 M
TEVA annual working capital is -$244.00 million

Liabilities

Annual Total Liabilities

$33.61 B
TEVA annual total liabilities is $33.61 billion

Annual Total Long Term Liabilities

$20.81 B
TEVA annual total long term liabilities is $20.81 billion

Annual Current Liabilities

$12.80 B
TEVA annual total current liabilities is $12.80 billion

Annual Accounts Payable

$2.20 B
TEVA annual accounts payable is $2.20 billion

Debt

Annual Total Debt

$18.08 B
TEVA annual total debt is $18.08 billion

Annual Total Debt 1-Year Change

-10.29%
TEVA annual total debt is down -10.29% year-on-year

Annual Long Term Debt

$16.30 B
TEVA annual long term debt is $16.30 billion

Annual Short Term Debt

$1.78 B
TEVA annual short term debt is $1.78 billion

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$13.18 B
TEVA annual total expenses is $13.18 billion

Annual Operating Expenses

$4.70 B
TEVA annual total operating expenses is $4.70 billion

Annual Cost Of Goods Sold

$8.48 B
TEVA annual cost of goods sold is $8.48 billion

Annual SGA

$3.70 B
TEVA annual SGA is $3.70 billion

Annual D&A

$1.06 B
TEVA annual depreciation & amortization is $1.06 billion

Annual Interest Expense

$1.00 B
TEVA annual interest expense is $1.00 billion

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$1.25 B
TEVA annual cash flow from operations is $1.25 billion

Annual CFO 1-Year Change

-8.85%
TEVA annual cash flow from operations is down -8.85% year-on-year

Annual CFI

$792.00 M
TEVA annual cash flow from investing activities is $792.00 million

Annual CFI 1-Year Change

-18.18%
TEVA annual cash flow from investing activities is down -18.18% year-on-year

Annual CFF

-$1.79 B
TEVA annual cash flow from financing activities is -$1.79 billion

Annual CFF 1-Year Change

+6.38%
TEVA annual cash flow from financing activities is up +6.38% year-on-year

Free CashFlow

Annual FCF

$749.00 M
TEVA annual free cash flow is $749.00 million

Annual FCF 1-Year Change

-11.05%
TEVA annual free cash flow is down -11.05% year-on-year

CAPEX

Annual CAPEX

$498.00 M
TEVA annual capital expenditures is $498.00 million

Annual CAPEX 1-Year Change

-5.32%
TEVA annual capital expenditures is down -5.32% year-on-year

Institutional Ownership

Similar stocks

PODD logo
Insulet (PODD)
DGX logo
Quest Diagnostics Incorporated (DGX)
BAX logo
Baxter International (BAX)
COO logo
Cooper Companies (COO)
NTRA logo
Natera (NTRA)
MOH logo
Molina Healthcare (MOH)
BIIB logo
Biogen (BIIB)
LH logo
Laboratory Corporation of America Holdings (LH)
ZBH logo
Zimmer Biomet Holdings (ZBH)

FAQ

  • What is the ticker symbol for Teva Pharmaceutical Industries Limited?
  • Does Teva Pharmaceutical Industries Limited pay dividends?
  • What sector is Teva Pharmaceutical Industries Limited in?
  • What industry is Teva Pharmaceutical Industries Limited in?
  • What country is Teva Pharmaceutical Industries Limited based in?
  • When did Teva Pharmaceutical Industries Limited go public?
  • Is Teva Pharmaceutical Industries Limited in the S&P 500?
  • Is Teva Pharmaceutical Industries Limited in the NASDAQ 100?
  • Is Teva Pharmaceutical Industries Limited in the Dow Jones?
  • When was Teva Pharmaceutical Industries Limited's last earnings report?
  • When does Teva Pharmaceutical Industries Limited report earnings?
  • Should I buy Teva Pharmaceutical Industries Limited stock now?

What is the ticker symbol for Teva Pharmaceutical Industries Limited?

The ticker symbol for Teva Pharmaceutical Industries Limited is NYSE:TEVA

Does Teva Pharmaceutical Industries Limited pay dividends?

No, Teva Pharmaceutical Industries Limited does not pay dividends

What sector is Teva Pharmaceutical Industries Limited in?

Teva Pharmaceutical Industries Limited is in the Healthcare sector

What industry is Teva Pharmaceutical Industries Limited in?

Teva Pharmaceutical Industries Limited is in the Drug Manufacturers - Specialty & Generic industry

What country is Teva Pharmaceutical Industries Limited based in?

Teva Pharmaceutical Industries Limited is headquartered in Israel

When did Teva Pharmaceutical Industries Limited go public?

Teva Pharmaceutical Industries Limited's initial public offering (IPO) was on February 16, 1982

Is Teva Pharmaceutical Industries Limited in the S&P 500?

No, Teva Pharmaceutical Industries Limited is not included in the S&P 500 index

Is Teva Pharmaceutical Industries Limited in the NASDAQ 100?

No, Teva Pharmaceutical Industries Limited is not included in the NASDAQ 100 index

Is Teva Pharmaceutical Industries Limited in the Dow Jones?

No, Teva Pharmaceutical Industries Limited is not included in the Dow Jones index

When was Teva Pharmaceutical Industries Limited's last earnings report?

Teva Pharmaceutical Industries Limited's most recent earnings report was on Jan 29, 2025

When does Teva Pharmaceutical Industries Limited report earnings?

The next expected earnings date for Teva Pharmaceutical Industries Limited is May 8, 2025

Should I buy Teva Pharmaceutical Industries Limited stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions